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I Summary 
 
The advances in drug delivery research regarding formulation strategies and technologies, and at the 
same time high regulatory demands for novel therapeutics, in turn require advanced analytical 
methods for their investigation. In this work, confocal Raman microscopy is successfully applied as a 
label-free, chemically selective and non-destructive method for in-depth analysis to gain insight into 
complex drug carrier systems, to understand cellular and non-cellular barriers in the human body, as 
well as to visualize drug and carrier uptake. The studies include examination of pellets and tablets, 
designed for controlled drug release, elucidation of mass transport mechanisms and in situ drug 
recrystallization upon drug release. Furthermore, the polymer distribution within bio-inspired 
polymeric fiber mats was visualized and successfully correlated to interactions of the fibers with 
human cells. Moreover, confocal Raman microscopy was used for investigation of human airway 
mucus microstructure, and for tracing molecular and structural changes upon chemical mucolysis. 
Further, the alveolar surfactant, was examined upon differentiation of primary epithelial lung cells 
utilizing both, linear and coherent Raman techniques. Finally, particle uptake into cells with different 
membrane properties was investigated by label-free intracellular trafficking of bioinspired therapeutics 
for targeted drug delivery. Altogether, this newly gained knowledge will help further advancement in 
drug delivery research beyond the current state-of-the-art. 
Zusammenfassung 
VII 
II  Zusammenfassung 
 
Die Fortschritte in der Entwicklung von Wirkstofftransporter-Systemen, insbesondere bezüglich 
neuerer Formulierungsstrategien und -technologien, und die hohen regulatorischen Anforderungen für 
neue Therapeutika erfordern hochentwickelte analytische Methoden für deren Untersuchungen. Im 
Rahmen dieser Arbeit wurde konfokale Raman Mikroskopie erfolgreich als eine markierungsfreie, 
chemisch selektive und nicht-destruktive Methode für eine detaillierte Analyse verwendet, um einen 
Einblick in komplexe Wirkstoffträgersysteme zu gewinnen, zelluläre und nicht-zelluläre menschliche 
Barrieren im menschlichen Körper zu verstehen, sowie Arzneistoffe und Partikel zu visualisieren. Die 
Studien umfassen Untersuchungen von Pellets und Tabletten für die kontrollierte Wirkstofffreigabe, 
erklären den Massentransportmechanismus und die in situ Wirkstoffrekristallisation nach 
Wirkstofffreisetzung. Darüber hinaus konnte die Polymerverteilungen innerhalb  bio-inspirierter, 
elektrogesponnener Vliese visualisiert und deren Interaktion mit den menschlichen Zellen korreliert 
werden. Außerdem konnte die konfokale Raman-Mikroskopie für die Untersuchung der Mikrostruktur 
von Mukus aus den humanen Atemwegen und zur Verfolgung molekularer und struktureller 
Veränderungen nach chemischer Mukolyse eingesetzt werden. Mit Hilfe linearer und kohärenter 
Ramantechniken konnte zudem das alveolare Surfactant während der Differenzierung primärer 
epithelialer Lungenzellen untersucht werden. Letztlich wurde die Aufnahme von Partikeln in Zellen 
mit unterschiedlichen Membraneigenschaften mittels markierungsfreier, intrazellulärer 
Nachverfolgung von bio-inspirierten Therapeutika für die zielgerichtete Arzneistoffapplikation 
analysiert. Das hier neugewonnene Wissen erlaubt somit weitere Fortschritte in der Forschung des 
Wirkstofftransports jenseits des aktuellen Wissensstandes. 
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III Abbreviations 
 
AFM   atomic force microscopy 
API   active pharmaceutical ingredient 
CARS   coherent anti-Stokes Raman scattering 
CRM   confocal Raman microscopy 
DPI   dry powder for inhalation 
ERL   Eudragit RL 
FU   fluorouracil 
IR   infrared 
MCC   microcrystalline cellulose 
MIR   mid infrared 
NIR   near infrared 
PAT   process analytical technology 
PCL   poly(ε-caprolactone) 
PLGA   poly(lactic-co-glycolic acid) 
PVP   polyvinylpyrrolidone 
PVP-VA  polyvinylpyrrolidone/vinyl acetate 
QbD   Quality by Design 
SEDDS  self-emulsifying drug delivery systems 
SEM   scanning electron microscopy 
SERS   surface enhanced Raman scattering 
SRS   stimulated Raman scattering 
TERS   tip-enhanced Raman scattering 
UV   ultraviolet 
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1 Introduction 
 
The constant advancement in formulation strategies and technologies applied in drug delivery research 
regularly necessitates cutting-edge analytical tools for versatile and comprehensive investigation of 
component distribution, drug release and/or degradation of novel therapeutics, as well their interaction 
with cells and tissues. In this context, confocal Raman microscopy represents a sophisticated analytical 
approach since it allows for label-free, chemically selective and non-destructive analysis. 
 
 
1.1 Raman Effect 
 
Upon interaction of light with matter, three characteristic phenomena may occur: transmission, 
absorption, and scattering, the latter being the most infrequent among the other effects, since it is a 
result of an inelastic collision of a photon with a molecule (Fig. 1A). This effect is described as Stokes 
scattering if the scattered photons loose energy, and anti-Stokes scattering if, in the rare case, the 
scattered photons gain energy. More precisely, Stokes scattering is detected at lower frequency (lower 
energy) and anti-Stokes scattering at higher frequency (higher energy) compared to the incoming 
photons. In the case of elastic scattering however, the scattered photons stay at the original vibrational 
level, retaining the same energy (so called Rayleigh scattering). Raman scattering is an inelastic 
scattering process in which vibrational modes in molecules are excited by the interaction with the 
incident light (1). A schematic illustration of the energy levels of incoming and outgoing photons for 
the different scattering effects is depicted in Fig. 1B. In this thesis, we used both, Stokes and anti-
Stokes scattering phenomena for analytical investigation and they will be compared in the following 
chapters. 
 
 
 
Figure 1. A. Schematic illustration of light scattering occurring upon interaction of light and matter. 
The major fraction of incident light is scattered elastically (λ). A small portion of the incident light 
however, is scattered inelastically (λ ± Δ); B. Energy level diagram illustrating anti-Stokes, Rayleigh 
and Stokes scattering; line thickness corresponds with the probability of appearance. 
 
 
When the excitation frequency changes, the frequency of Raman scattered light is also changing. In 
order to track those wavelength changes between incident and scattered light, monochromatic laser 
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light is used to obtain a Raman scattering signal from a sample. The energy difference between the 
excitation frequency and the frequency of the Raman scattered light is a constant attribute for a given 
Raman band. Consequently, a Raman spectrum (Fig. 2) represents a plot of the scattered intensity 
versus the energy difference between the incident and scattered photons (“Raman shift”). 
 
Figure 2. A Raman spectrum of a human cell composed of spectral contributions from proteins, 
nucleic acids and lipids.   
 
 
The Raman shift is characteristic for molecular vibrations representing specific molecular functional 
groups. Consequently, the Raman scattering pattern is specific for a particular chemical structure and 
resembles a specific “molecular fingerprint”. Based on their composition, Raman spectra of cells for 
example (Fig. 2), usually consist of spectral contributions from proteins (phenylalanine, amide I, 
amide II, CH, CH2 and CH3 vibrations), nucleic acids (O-P-O vibrations) and lipids (CH, CH2 and CH3 
vibrations) (2). Furthermore, the count of scattered photons at a defined Raman shift and therefore the 
signal intensity linearly correlates with the quantity of the represented molecule. 
 
The position of a line in the Raman spectrum corresponds to the energy that is required to excite a 
molecule to a certain vibrational energy level. A molecule can have up to 3N-6 independent 
vibrational modes (3N-5 for linear molecules), where N is the number of atoms in the molecule. 
Molecular vibrations are often classified into groups that are intuitively descriptive of the vibrational 
motion. An oscillation in bond length is called a “stretch”, an oscillation in bond angle is called a 
“deformation” or “bend”, etc. 
 
Raman scattering measures vibrational transition energies from about 17 to 4000 cm-1, which is nearly 
equivalent to the entire spectral ranges covered by far- and mid-infrared spectroscopy together. In 
contrast to other vibrational spectroscopy methods, Raman excitation frequencies can range from the 
ultraviolet (UV) to the near-infrared region (NIR), thus making the technique very flexible. 
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1.2 Spontaneous Raman Scattering 
 
The quantum mechanical model for Raman scattering was first described by Placzek (3). He discusses 
several aspects of Raman scattering that are of practical importance for chemical imaging. First of all, 
the intensity of Raman scattering is proportional to the excitation intensity. However, there is a 
practical limitation for this phenomenon, since strong monochromatic lasers can overheat and damage 
the sample. Furthermore, the intensity of Raman scattering is proportional to the number of scattering 
molecules and to the fourth power of the Raman photon frequency. Moreover, Raman sensitivity 
increases quickly with increasing excitation frequency (decreasing wavelength) because the Raman 
photon frequency increases along with it. Placzek’s complicated quantum mechanical model can be 
rewritten in an analytically useful form similar to Beer’s law: 
 
IR = (IL σR X)PC     (Equation 1) 
 
where IR is the measured Raman intensity, IL is the laser intensity, σR is the absolute Raman cross 
section, X is the experimental constant, P is the sample path length, and C is the concentration. 
 
Here, characteristics of detectors and optics properties are represented by the experimental constant X, 
and the strength of a Raman band by the Raman cross section. 
 
The sensitivity of spontaneous Raman scattering represents one of the biggest obstacles for Raman 
spectroscopy as an analytical tool, especially when analyzing cells, tissues, or biological samples in 
general. Furthermore, for simultaneous detection of cells and a drug to investigate their interactions, a 
significant spectral contrast is required for identification. When dealing with small concentrations of 
the drug or bioinspired chemical entities, such as peptide drugs or nucleoside analogues, this is in 
many cases hardly possible. Thus, chemical structures such as alkyne or isotopes deuterium have 
gained considerable attention as their scattering can be detected in the spectral “silent region” 
(between 1800 – 2800 cm-1), in which no significant spectral contributions of other 
biomacromolecules are observed. In contrast to often bulky fluorescence marker molecules, deuterium 
can be introduced into a molecule without significantly changing its physicochemical characteristics 
(4-8). 
 
Another obstacle often happening upon detection of Raman scattering and quantitative analysis is 
sample noise. Noise is any detected signal which can hinder the detection of the measured analyte. The 
most serious noise source in Raman spectroscopy is fluorescence, which (due to emitted longer 
wavelength) overshines scattered photons. Many experimental and mathematical approaches have 
been used to reduce the impact of fluorescence on Raman analysis, but there is still room for 
improvement. Another noise source can be a sample matrix in which the analyte of interest is 
distributed. A solvent or excipient, for example, present at high concentration, may obscure the 
spectrum of an analyte present at much lower concentration. 
 
In order to obtain spatially resolved Raman information, nowadays a Raman spectroscope is usually 
combined with a confocal microscope. A single Raman spectrum of the random spot on the sample 
surface provides chemical information about the sample composition. Furthermore, when analyzing 
the area of interest, Raman spectra can give an insight into chemical composition and its changes as a 
function of spatial position. Raman spectra can also be collected along a lateral or axial line/surface. 
When Raman spectra are acquired along an axial line/surface, the measurement is called a depth 
profile. Two dimensional spectral data sets can be transformed into spectral maps or images, after 
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single spectra are collected from each pixel. The spectral information can be later transformed into 
false color images to visualize the different components. Three-dimensional measurements include the 
assembly of multiple maps to a picture stack, similar to confocal fluorescence imaging. 
 
Every Raman mapping or imaging must be at least semiquantitative, since the relative Raman intensity 
among pixels is proportional to concentration. Semiquantitative Raman imaging may approximate 
relative analyte concentration with or without knowledge of the absolute concentration. Another 
semiquantitative approach is to classify each pixel into groups representing all components of the 
system, and then to report analyte concentration as the fraction of pixels classified as that analyte (9). 
If the samples are exhibiting minimal diffuse reflection, quantitative analysis can be more promising. 
The basis for quantitative analysis using Raman scattering can be explained by Equation 1, which 
describes a direct proportion between Raman intensity and analyte concentration. However, the 
Raman cross section, the instrument detection efficiency, and the path length are usually unknown. An 
image based on uncorrected Raman intensity may provide a qualitative description of analyte 
distribution, but that distribution may be distorted by many controlled variables, such as focusing 
errors due to an uneven sample surface or path length variation (10). 
 
One way to improve focusing on the sample surface, which can drastically impede further Raman 
investigation, is to combine Raman microscopy with optical profilometry. This is a method based on 
white light which enables three-dimensional mapping of the area of interest (11). By acquiring a 
topography profile prior to Raman spectroscopy, the profile height information allows for leveling the 
focal plane to the sample surface for each spectrum acquisition. 
 
In addition to spontaneous Raman scattering, there are several other types of Raman spectroscopy, 
such as resonance Raman scattering spectroscopy (12, 13), coherent anti-Stokes Raman spectroscopy 
(CARS), stimulated Raman spectroscopy (SRS), surface-enhanced Raman spectroscopy (SERS) (14), 
and tip-enhanced Raman spectroscopy (TERS) (15). Each of them has its own capabilities and 
limitations. Here, we will briefly introduce non-linear Raman techniques, CARS and SRS microscopy, 
as they are particularly useful for chemical imaging. 
 
 
1.3 Non-linear Raman Scattering 
 
The major drawback of spontaneous Raman microscopy is the low Raman scattering signal, which as 
a consequence results in long integration times. In addition, many samples display autofluorescence, 
which often prevents the detection of a Raman signal. In order to increase the Raman sensitivity by as 
much as ten orders of magnitude and overcome these limitations, non-linear optical Raman techniques, 
namely coherent anti-Stokes Raman scattering (CARS) and stimulated Raman scattering (SRS) 
microscopy have been developed in the last two decades (16-20). 
 
For both approaches, two laser beams with intensities Ipump and IStokes are irradiating the sample. Their 
signal intensities do not linearly depend on the excitation intensity (non-linear principle), but 
quadratically (SRS) or cubically (CARS), which as a consequence, enhances the probability of light 
scattering and reduces the time for analysis: 
 
ISRS ∝ N σRaman Ipump IStokes    (Equation 2) 
 
and 
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ICARS ∝ | χ(3)|2 I2pump IStokes    (Equation 3) 
 
Here, σRaman is the Raman scattering cross section and χ(3) is the third order non-linear optical 
susceptibility.  
 
The third-order susceptibility consists of the sum of a resonant part that is enhanced by molecular 
vibrations and a nonresonant part (background signal) due to the electronic response of the material 
that is not enhanced by molecular vibrations. Since χ(3) is proportional to the number of molecules, the 
two equations can explain an important difference between SRS and CARS. SRS has a linear 
dependence on the concentration of probed molecules, whereas CARS has a quadratic dependence. 
Detection of CARS signals (ωCARS = 2 ωpump - ωStokes) is easier compared to SRS, as they have the 
frequency different from that of the excitation light and, in addition, allow for simultaneous detection 
with two-photon excited fluorescence emission and/or second (third) harmonic generation signals. 
SRS signals, on contrary, are detected as a loss or gain in energy compared to the incident light, which 
in turn allows for simpler quantitative interpretation. 
 
However, both qualitative and quantitative analyses of spectra are more difficult for CARS than for 
spontaneous Raman spectroscopy. Numerous approaches have been proposed to reduce the 
background signal (nonresonant background) and improve the CARS signal. One of them is 
demonstrated by collecting of the backscattered anti-Stokes signals from thin samples (epi-CARS) 
which in a great extent reduced the nonresonant intensity from the matrix. A second approach is to use 
near-infrared pump wavelengths. The nonresonance anti-Stokes intensity can be enhanced if the pump 
wavelength is near a two-photon absorption band of the sample. Further distortion of CARS spectra 
can occur from interferences between resonances. For example, one band height can influence the 
height of a neighboring band. The quadratic dependence of CARS intensity on analyte concentration 
complicates the resolution of overlapping bands from different materials, as well as the use of standard 
multivariate analysis algorithms. 
 
All in all, the autofluorescence, different integration times and the spectral latitude are the three main 
differences between spontaneous Raman microscopy and nonlinear Raman techniques. Non-linear 
Raman imaging is insensitive against an autofluorescent background, because the Raman and the 
fluorescence signal are not coinciding. Further, non-linear Raman imaging is several orders of 
magnitudes faster, with video-rate imaging being achievable (21-23). However, most non-linear 
Raman microscopy instruments probe only one vibrational resonance at a time which as a result has 
reduced spectral information compared to spontaneous Raman microscopy. Nevertheless, a broadband 
CARS has been recognized as a very promising approach to circumvent the last obstacle (24-29). With 
this method, it is possible to measure multiple anti-Stokes CARS wavelengths simultaneously by using 
a spectrally broad source for the Stokes beam. Acquisition times per pixel are increased for several 
reasons including distribution of Stokes beam intensity over many spectral resolution elements, but 
still much faster than those of spontaneous equivalent. Further development of the broadband CARS 
and SRS, as well as their growing application in the pharmaceutical field can be expected. 
 
 
1.4 Pharmaceutical and Biomedical Applications of Raman Spectroscopy 
 
Almost a century after discovery of the Raman effect (1), advanced analytics based on this effect are 
gaining increasing attention for a wide range of different pharmaceutical and biomedical applications. 
In contrast to established analytical techniques, Raman spectroscopy provides label-free, non-
destructive, chemically selective and spatially resolved analysis. Advanced technical development in 
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the last decades allowed Raman spectroscopy for implementation into diverse setups ranging from 
confocal microscopes for acquisition of three-dimensional spectral information up to fiber devices for 
the application in clinical diagnostics. Furthermore, recent progress in the field of multivariate data 
analysis used for processing complex spectral data sets significantly facilitated data interpretation. 
 
Raman techniques are implemented in different stages of pharmaceutical development ranging from 
drug discovery up to the development of drug-loaded carrier systems (30). An important part of the 
preformulation phase is solid-form screening which can help avoiding problems during later stages of 
drug development (31-33). The rapid and non-invasive analysis of powders allowed Raman 
spectroscopy for implementing into different high-throughput and low quantity screening platforms of 
active pharmaceutical ingredients (APIs) including polymorph and cocrystal screening (34-36). 
Moreover, Raman spectroscopy has been used for studying phase transformations such as polymorphic 
changes, anhydrate-hydrate transitions and amorphization (37-40), as well as for identifying the 
mechanisms of co-crystal formation (41, 42). 
 
Raman spectroscopy can be also applied for microstructural characterization of drug delivery systems, 
as well as for studying drug-excipient interactions in the formulation. It has been used to control the 
size distribution of API microparticles and to determine the API distribution homogeneity in tablets 
(43, 44). Furthermore, Raman spectroscopy is widely applied for characterization of amorphous solid 
dispersions, formulated to improve the solubility of the poorly soluble actives (45). The nature of 
water molecules in hygroscopic amorphous polymer matrices such as polyvinylpyrrolidone (PVP) and 
polyvinylpyrrolidone/vinyl acetate (PVP-VA) copolymers was determined using FT-Raman 
spectroscopic analysis as a function of moisture content (46). 
 
Confocal Raman microscopy is also being used to characterize printed drug delivery systems (47, 48), 
and three-layered tablets (49). In combination with optical topography (11), in one of the studies, 
Raman revealed the reason for different erosion indexes in two formulations. Water soluble mannitol 
was not present on the tablet surface after soaking in the nanocapsule suspension. Microcrystalline 
cellulose (MCC), however, was visualized on the surface (Fig. 3B, MCC depicted in blue) (48). 
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Figure 3. False color Raman images of 3D printed tablets: (A) T-ERL-M and (B) T-ERL-A. Eudragit 
RL (ERL) is depicted in red, while mannitol (M, figure A) or microcrystalline cellulose (A, figure B) 
are depicted in blue in the respective image. Reproduced with permission from (48). 
 
 
Besides, Raman imaging has been used to better understand drug migration during dissolution, and 
obtain a mechanistic insight into the drug release from the complex matrix systems (50). In situ Raman 
imaging during dissolution has been also reported (45), however non-linear Raman technologies 
represent a more reliable solution for these purposes, due to much faster acquisition times (51-53). 
 
Raman spectroscopy can be also useful for characterization of stents and implants. The microstructure 
of drug eluting stents is difficult to investigate using conventional analytics because of the distribution 
of the formulation as a thin coat over the wire. In this context, Raman was used to analyze rapamycin/ 
poly(lactic-co-glycolic acid) - PLGA coatings on stents, from the surface through the bulk of the 
coatings (54). For these purposes Raman is often combined with atomic force microscopy (AFM) 
which gives the best topographical overview. In combination, these two methods allowed for a 
comprehensive study on sirolimus-eluting coronary stent and explained the correlation between drug 
release and device microstructure and pore networks (55). 
 
Raman spectroscopy and imaging have been also successfully employed for the characterization of 
lipid-based drug delivery systems (56). Here, Raman was used to investigate the homogeneity of semi-
solid self-emulsifying drug delivery systems (SEDDS) (57). Moreover, it was applied to investigate 
the release from liposome formulations (58). Furthermore, Raman spectroscopy can be applied to 
monitor in vitro drug dispersion, lipolysis and supersaturation of lipid-based formulations (59). 
 
The spatial drug distribution on the carrier surface is challenging but very important when testing the 
aerodynamics and API lung deposition from dry powder for inhalation (DPI). Here, confocal Raman 
microscopy is used for fast analysis of content uniformity, homogeneity and the polymorphic form of 
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a drug distributed within a spray-dried inhalable powder (60). Moreover, Raman spectroscopy was 
shown to exhibit an excellent ability to distinguish the amorphous and crystalline form from a small 
mass fractions of API (<3% w/w) (61). One more study proved the advantage of two component 
system in a single inhalation device compared to using separate inhalers (62). Recently, CARS 
imaging was applied as a useful tool to identify drug particle clusters on the carrier surface of a DPI 
formulation (63). 
 
With respect to process monitoring, Raman spectroscopy is considered as a feasible process analytical 
technology (PAT) tool in pharmaceutical industry. Thanks to the ability to obtain a real-time 
information on a molecular level during pharmaceutically relevant unit operations, Raman is applied 
for following various processes during production (64). For example, Raman spectroscopy is very 
reliable for monitoring batch crystallization which is performed in aqueous environment. Here, Raman 
represents a good alternative to infrared (IR), since water exhibits a strong absorption in the IR region. 
Thus, the process control and monitoring the polymorphic change upon crystallization can be followed 
by Raman spectroscopy (65-67). Raman has been applied to monitor synthesis and fermentation of 
antibiotics (68, 69). Furthermore, Raman was applied as a PAT tool for testing the desired 
intermediate product in several other unit operations (70), such as blending (71), granulation (72, 73), 
and coating (74-76). Moreover, Raman spectroscopy has also been applied for inline and real-time 
monitoring of the hot melt extrusion (77, 78) and freeze-drying process (79-81). 
 
Besides the early phase chemical screening during preformulation, as well as formulation in late phase 
pharmaceutical development, Raman is also used in product performance testing and quality control of 
the final product upon market entry. Most of pharmaceutical actives are good scatterers; however this 
is often not the case with excipients. Although not wide-ranging and comprehensive like IR, Raman 
databases are also available (82). A Raman device is useful for content uniformity determination in 
solid oral dosage forms such as tablets (83, 84). For example, Raman imaging was applied to track the 
degradation of acetaminophen in a tablet (85), or for the material identification through the blister or 
vial, without sample preparation (86, 87). In situ Raman spectroscopy was used to quantify 
intermediate to final solid forms generated during the dehydration of hydrate forms of piroxicam and 
carbamazepine (88). Fiber optic Raman probes are often used nowadays for in situ monitoring of drug 
release testing in different in vitro dissolution apparatuses and flow-through devices (89). In addition 
to conventional Raman systems, CARS microscopy has also been increasingly used to study in vitro 
drug dissolution from different solid dosage forms (90, 91). 
 
Even though fluorescence microscopy is still the most commonly applied technique for physiological 
investigations, Raman microscopy is paving its way as a suitable alternative without the necessity for 
bulky labelling (92). However, visualizing the API within a dosage form is much easier compared to 
locating it in more demanding biological samples such as cells or tissues. Here, a brief summary is 
given of a quite complex approach to apply Raman for biomedical investigations. 
 
One of the first single cell studies using micro-Raman spectroscopy were performed in order to study 
DNA-protein complexes within cellular microenvironment (93). Since then, Raman spectroscopy has 
been applied to study the physiology of a broad range of cell types: prokaryotic, eukaryotic, and plant 
cells (2, 94). Further on, the aim was shifted towards comparing Raman scattering patterns of cells to 
differentiate between healthy and neoplastic cells (95, 96), or to follow differentiation process of stem 
cells (97, 98). Moreover, Raman spectroscopy can be combined with microfluidic systems which 
allows for cellular investigations and cell sorting in a flow (99, 100). 
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Raman investigation of  individual sperm cells helped assessing DNA packaging efficiency in the 
sperm heads, suggesting that selecting viable sperm cells for in vitro fertilization solely based on 
morphology may not be sufficient (101). Single cell Raman spectroscopy is also used to monitor the 
deoxygenation and oxygenation of hemoglobin inside human erythrocytes for a duration of 30 minutes 
(102, 103), as well as for the analysis of erythrocyte disorders characterized by heme aggregation, 
such as sickle cell disease and malaria (104). Moreover, in combination with optical tweezers, Raman 
is used to monitor the intracellular ethanol accumulation in yeast cells (105). 
 
As mentioned in the second chapter, Raman-active labelling of small molecules or proteins, carrying 
stable isotopes (deuterium, for example), facilitates and sometimes enables the detection and imaging 
of these molecules by spontaneous Raman spectroscopy (6-8). The similar benefit was shown by 
visualizing molecules carrying alkyne groups inside of the cell (106, 107). 
 
Due to the label-free principle, vibrational spectroscopy techniques have received increased attention 
in cell-based drug screening studies (108, 109). Allowing for monitoring cellular kinetics in real-time, 
Raman chemical imaging enables testing the effect of drug, and drug combinations at different time 
points, in order to determine optimal concentrations and treatment conditions. Raman spectroscopy is 
particularly attractive for small molecules investigations, when molecular size of fluorescent dyes 
exceeds the size of the molecule of interest. Cellular biomacromolecules used as biochemical markers 
and introduced synthetic drugs, both with individual Raman scattering patterns, can be examined 
simultaneously in order to investigate the effects and interactions between cells and drugs without 
external labels. This smart principle was applied for studying the response of cancer cells to drugs 
(substance cleavage or cell apoptosis) (110). As an example, the treatment of gastric carcinoma cells 
with fluorouracil (5-FU) was followed by the reduction in vibrational band intensities of cellular 
biomacromolecules, signifying apoptosis (111). The mechanism of action of the anticancer drug 
etoposide was proved by decreasing DNA and RNA concentrations upon treatment of human 
pneumocyte-like cells (A549) (112). Real-time measurements of living human cancer cells undergoing 
apoptosis has been also reported (113). 
 
Raman microscopy has also been used to reveal the mechanism and efficacy of anticancer agents. 
Spectral changes in cell membrane and different cytoplasmic regions of A549 adenocarcinoma cells 
were characterized after treatment with cisplatin (114). Advanced multivariate methods in this case 
could enable to predict the viability according to exposure dose. 
 
Although very promising, spontaneous Raman spectroscopy is still a relatively slow technique, 
requiring at least an acquisition time of 1s per cell, in the best possible case. Because of this, high 
throughput measurements on the order of hundreds or thousands of cells are still a missing gap. To 
overcome this, some research groups work on compressed sensing, by using micro-mirror devices 
which can lower the data acquisition time per spectrum by 1-2 orders of magnitude (115, 116). For 
even faster approaches, it is possible to apply the multiplexed coherent Raman spectroscopy, as well as 
the combination with microfluidic chips, to truly achieve rapid Raman-assisted cell sorting (117). 
 
Besides biochemical changes occurring intracellularly upon drug exposure, Raman can serve for 
studying drug delivery systems distribution within the cell. So far, Raman microscopy was used to 
image the intracellular distribution of cationic liposomes in HeLa cells (118), and polystyrene 
nanoparticles internalized by A549 cells (119). Furthermore, Raman spectroscopy could potentially be 
used to provide insights into drug targeting mechanisms (120). 
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Raman spectroscopy is also successfully applied for analyzing even smaller organisms, bacterial cells. 
Together with optical trapping, Raman spectroscopy could rapidly identify individual endospores in 
suspension and discriminate them from particles (121). Besides, it is possible to distinguish the 
bacterial spores from cells in vegetative state (122, 123). Furthermore, subtle differences in Raman 
spectra of different bacterial species make possible the identification of many microorganisms of 
clinical relevance (124, 125). The high spatial resolution of confocal Raman microscopy allows for 
tracking the physiological dynamics in individual bacterial cells, for example overexpression of 
proteins in genetically modified bacteria (126). Finally, bacterial cells can be tested after exposure to 
antibiotic drugs by following the evolution of Raman bands associated with DNA, RNA and proteins 
(127, 128). 
 
The application of methods based on Raman spectroscopy in the pharmaceutical and biomedical field 
is very broad. This is partly due to the very fast development of instrumentation which ranges from 
self-built systems with high scientific performance abilities, up to low resolution portable instruments, 
altogether allowing for multi-stage pharmaceutical research. This includes early phase chemical 
screening and solid form characterization during preformulation as well as formulation analytics in 
late phase development. Furthermore, innovative fiber optics-based Raman probe seem to have a 
versatile application for PAT analysis. The anticipated future trend of continuous manufacturing in the 
Quality by Design (QbD) framework started including Raman instrumentation adaptable to a wide 
variety of unit operations. Also, the current development of super-resolution optical microscopy 
techniques, awarded with the Nobel Prize in Chemistry in 2014, started influencing the other 
fluorescence-free imaging techniques. Raman imaging, both for in vitro and in vivo application, is 
offering a great future potential, but still leaving space for further improvement of the methods based 
on Raman scattering.  
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2  Aims 
 
The main goal of this thesis is to apply confocal Raman microscopy for in depth analysis of complex 
drug delivery systems, investigation of cellular and non-cellular lung barrier and alveolar surfactant 
secretion, as well as for visualization of cellular interaction with bio-inspired nanocarrier systems. In 
addition, this involves a critical evaluation of the advantages as well as the limitations of this 
technique for pharmaceutical applications. In this context, three major aims were followed: 
 
 
1. To elucidate drug release mechanisms and identify correlations between drug distribution and 
excipients` properties on drug release from the respective delivery systems. 
 
2. To analyze the microstructure of the human airway mucus and secretion of alveolar surfactant 
associated with alveolar epithelial cell differentiation in order to investigate the non-cellular 
human lung barrier. 
 
3. To investigate bioinspired particle uptake by cultured human cells on the subcellular level 
after applying deuterization as an approach for increasing Raman sensitivity of the molecule 
of interest. 
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3  Results and Discussion 
 
3.1 Influence of Component Distribution on Drug Release from Solid Dosage Forms by 
Confocal Raman Microscopy 
 
 
This chapter refers to the following publications: 
B. Vukosavljevic, L. De Kinder, J. Siepmann, S. Muschert, M. Windbergs; Novel insights into 
controlled drug release from coated pellets by confocal Raman microscopy. J. Raman Spectrosc. 2016, 
47:757-762. 
 
K. Puncochova*, B. Vukosavljevic*, J. Hanus, J. Beranek, M. Windbergs, F. Stepanek; Non-invasive 
insight into the release mechanisms of a poorly soluble drug from amorphous solid dispersions by 
confocal Raman microscopy. Eur. J. Pharm. Biopharm. 2016, 101:119-25. 
* These authors contributed equally to this work. 
 
V. Planz, S. Seif, J.C. Atchison, B. Vukosavljevic, L. Sparenberg, E. Kroner, M. Windbergs; Three-
dimensional hierarchical cultivation of human skin cells on bio-adaptive hybrid fibers. Integr. Biol. 
2016, 8(7):775-84. 
 
 
Due to increasing complexity of novel chemical entities and their corresponding therapy schemes, the 
development of advanced therapeutics often requires sophisticated approaches, formulations and 
technologies for the final design of drug delivery systems. In turn, those systems regularly necessitate 
advanced methods for their comprehensive analytical investigation. 
 
There is broad range of complementary visualization techniques used in the pharmaceutical field. One 
common method is scanning electron microscopy (SEM). SEM is a valuable tool for imaging drug 
delivery systems with high spatial resolution however SEM lacks chemical selectivity, operates under 
vacuum and bares the risk of sample destruction. Furthermore, confocal fluorescence microscopy is a 
powerful technique allowing for chemically selective and spatially resolved analysis, however staining 
and fixation used for sample preparation can often influence component distribution as well as tracing 
of distribution changes upon the contact with different fluids. Additionally, vibrational spectroscopy 
methods, such as infrared (IR), near infrared (NIR) and Raman spectroscopy represent upcoming 
analytical tools, as they allow for label-free and chemically selective analysis. However, water exhibits 
a strong absorption in the IR region, thus hindering analysis during release testing in aqueous medium. 
In addition to this drawback, visualization of delicate changes within the system often requires high 
spatial resolution, which can also be a limitation for IR and NIR microscopy. 
 
In contrast, confocal Raman microscopy (CRM) represents a non-invasive, spatially resolved and 
chemically selective method, allowing for sample investigation in its unperturbed state, thus 
overcoming some of the previously mentioned obstacles. In the last two decades CRM was applied for 
microstructural characterization and better understanding of interactions between different components 
within diverse dosage forms (129) as for instance solid dispersions (130-133), drug-eluting coatings 
(134-136), polymeric microparticles (137-139), tablets (140-142), etc. 
 
In this thesis, we applied CRM for systematic characterization of three different drug delivery systems: 
coated pellets, tablets based on amorphous solid dispersions and electrospun fiber mats, in order to 
analyze component distribution, elucidate mechanisms of degradation and drug release, as well as to 
better understand the influence of formulation approaches on the final product characteristics. CRM 
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not only allowed for spatially resolved analysis of drug(s) and excipients (matrix components, coating 
agents, etc.), but also their changes in the distribution upon degradation and drug release testing, as 
well as for elucidation of the drug release mechanisms from advanced drug delivery systems. 
 
Nevertheless, like all the other confocal microscopy techniques, CRM investigates one focal plane at a 
time, thus preventing investigation of highly structured sample surfaces. In order to avoid invasive 
methods for sample preparation, as for example polishing, whenever it was necessary, we applied 
optical topography prior to Raman spectroscopy, as a complementary analytical approach (11). Optical 
topography analysis is based on white light and enables three-dimensional mapping of topographic 
height differences. Subsequently, acquisition of Raman spectra is directed by the topographic 
information of the sample, so the microscope focus at each pixel is individually adjusted according to 
the sample topography. The recorded Raman spectral data set is finally converted into a false color 
image, using diverse multivariate data methods. In the presented studies, we applied hierarchical 
cluster and basis analysis as two different multivariate statistical methods for data post-processing. 
Hierarchical cluster analysis encompasses a binary approach which results into “Boolean” images. 
Each pixel is assigned to one of the clusters, which represent Raman spectra of different chemical 
compounds. In contrast, basis analysis comprises acquiring the Raman spectra of individual 
compounds from the sample as references. Subsequently, the false color images illustrate the relative 
congruence of the spectra with the predefined reference spectra for each pixel. This is a non-binary 
approach which allows for a simultaneous display of multiple components in one single pixel, 
visualized by color intensity differences. This sophisticated multivariate methodology provides a more 
detailed visualization of the compound distribution. 
 
Coated pellets 
 
Multi-particulate carrier systems such as pellets, in comparison with single-unit delivery systems like 
tablets and capsules, offer certain therapeutic advantages allowing for simplified and individual dosing 
and improved patient compliance. The release of active pharmaceutical ingredient/s (API) integrated 
into pellets can be controlled by convective and/or diffusive mass transport within the pellet matrix. 
Moreover, in order to protect embedded actives and/or control their release, pellets can be coated with 
a polymeric film which modify and control drug release properties and associated mass transport 
mechanisms. Here, we applied CRM for non-destructive and chemically selective analytical 
investigation of coated drug-loaded pellets in order to visualize compound distribution before and after 
dissolution testing and elucidate drug release mechanisms. 
 
Pellet cores were prepared by extrusion-spheronization based on a mixture of lactose monohydrate and 
microcrystalline cellulose as matrix formers, and verapamil hydrochloride as a weak base model drug 
(10% w/w drug loading). In the subsequent step, pellet cores were coated in a fluidized bed setup with 
a polymer mixture consisting of Kollicoat® SR 30D - aqueous polyvinyl acetate dispersion, and 
Kollicoat® IR – polyvinyl alcohol-polyethylene glycol graft copolymer (90:10 w/w), to control drug 
release from the pellet core. In this study, we applied three complementary approaches for pellet 
investigation: 1. cross sections analysis after bisectioning (xy); 2. non-invasive whole pellet 
visualization (xy); and 3. non-invasive virtual cross sectioning - depth profiles (xz), all of them guided 
by an optical topography profile.  
 
As a first step, spectral investigation of individual pellet compounds was necessary in order to 
determine suitable peaks for their later identification and visualization within the drug delivery system. 
After analysis of the pellet cross sections, we could successfully visualize drug, pellet matrix as well 
as film coating compounds based on their individual Raman peak patterns, with high spatial 
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resolution. Prior to dissolution testing (Fig. 4A, left), coating film (depicted in yellow) was intact and 
verapamil hydrochloride (depicted in red) was rather homogeneously distributed within the pellet 
matrix (depicted in blue). After 45 minutes dissolution testing in acetic buffer pH 3.5 (Fig. 4B, left), 
we could visualize complete drug release from the pellet matrix and partly film coating disruption.  
 
However, pellet bisectioning can dramatically affect the original sample state, due to involved 
mechanical stress, and sometimes it was unfeasible to differentiate between defects occurred upon 
fabrication or upon sample preparation. Consequently, non-invasive methods became necessary for 
investigation of coating integrity. The Raman investigation of the whole pellet (second visualization 
approach) demonstrated the intactness and coherence of the coating film before release testing. 
However, after release testing, some parts of the film were indeed no longer intact. In those areas the 
Raman signal of the pellet matrix was detectable, leading to assumption that immediate release 
polymer from the coating film (Kollicoat® IR) was dissolving in the dissolution medium, leaving pores 
in the coating film.  
 
Despite the usefulness of the whole pellet visualization, this approach does not allow for tracing the 
changes in the pellet core upon dissolution testing. Therefore, we applied virtual cross sectioning in x-
z direction (depth profiles), as a third experimental approach. The penetration depth of the laser 
through non-transparent media such as pellet is of course limited. Here, the challenge was to 
successfully optimize the laser power, in order to reach the maximum penetration depth without 
sample damage. Before dissolution testing, depth profiles enabled detection and visualization of an 
intact coating layer, as well as the matrix and the drug beneath it, up to the depth of around 100 μm 
(Fig. 4A, right). After 45 minutes dissolution testing in acetic buffer pH 3.5 (Fig. 4B, right), however, 
we non-invasively visualized the pore formation (Fig. 4B, marked with an arrow) within the coating 
layer as well as drug depletion from the matrix due to contact with the release medium. 
 
 
 
Figure 4. Cross sections and virtual cross sections of pellets before (A) and after release testing (B). 
False colors depict the matrix in blue, film coating in yellow and the drug in red, respectively. 
Reprinted from B. Vukosavljevic, L. De Kinder, J. Siepmann, S. Muschert, M. Windbergs; Novel 
insights into controlled drug release from coated pellets by confocal Raman microscopy. J. Raman 
Spectrosc. 2016, 47:757-762, Copyright (2016), with permission from John Wiley & Sons, Ltd. (50) 
 
 
Pore formation within the coating film is most likely playing the key role in controlling drug release 
from the pellet core, as it allows for more rapid drug transport upon contact with the release medium. 
Furthermore, close to the visualized pores there was no drug detectable close to the coating film, 
illustrating complete drug release. 
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Altogether, non-invasive pellet surface visualization and virtual cross sectioning, represent a good 
complementary approach to bisectioning for comprehensive investigation of coated drug delivery 
systems, ranging from compound distribution and its changes upon release testing, up to elucidation of 
complex drug release mechanisms. 
 
Tablets based on amorphous solid dispersion 
 
The formation of amorphous solid dispersions via hot-melt extrusion or solvent evaporation (i.e. spray 
drying) represent one of the most successful approaches for increasing solubility and dissolution rate 
of poorly soluble APIs. However, despite better wettability properties and particle size reduction, solid 
dispersions are susceptible to thermodynamic instabilities resulting in recrystallization of the API upon 
storage or dissolution. In this respect, the crucial factor in the development of stable amorphous solid 
dispersion is the complexation effect of the polymer and the ability of the matrix to incorporate and 
stabilize a homogenously dispersed amorphous API. At the same time, in vitro dissolution profiles 
represent a very critical parameter of every formulation, as only a stable and reproducible API release 
from the delivery system enables a safe and effective drug therapy. In this study, our aim was to 
investigate in situ drug release and recrystallization mechanisms of a poorly water soluble model drug 
from amorphous solid dispersions and to elucidate the influence of polymer properties on stability and 
release behavior of API from those systems. 
 
Solid dispersions based on either Soluplus® (polyvinyl caprolactam-polyvinyl acetate-polyethihylene 
glycol graft copolymer) - an amphiphilic copolymer and solubilizer, or polyvinylpyrrolidone K30 
(PVP) - a hydrophilic polymer, and aprepitant, a poorly water soluble model drug, were in the first 
step successfully prepared by spray drying (drug:polymer 1:3, w/w). The formation of amorphous 
solid dispersions in both formulations was confirmed by differential scanning calorimetry (DSC) 
which showed one glass transition temperature with a significant decrease compared to the pure 
polymers. In the next step, the spray-dried particles were compressed to 7mm tablets, as a final dosage 
form.  
 
Although aprepitant in both cases exhibited its amorphous form, the cumulative release profiles of the 
two formulations were significantly different (Fig.5). The release from the Soluplus® matrix was slow 
but steady, and followed a linear kinetic. Visually, tablets based on Soluplus® swelled without 
observation of erosion, thus forming a diffusion barrier for aprepitant. The release from the PVP 
matrix, however, was different. Due to the good PVP solubility in water, in the first 60 min. drug 
release was faster, but between 60 and 480 min., the slopes of the release curves from both matrices 
were similar. However, after 480 min. aprepitant precipitated and its bulk concentration dramatically 
decreased. Unlike Soluplus®, the swollen PVP matrix was susceptible to erosion. 
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Figure 5. Cumulative release profiles of aprepitant from tablets compressed of spray-dried particles of 
amorphous solid dispersions of aprepitant in Soluplus and PVP. 
Reprinted from K. Puncochova, B. Vukosavljevic, J. Hanus, J. Beranek, M. Windbergs, F. Stepanek; 
Non-invasive insight into the release mechanisms of a poorly soluble drug from amorphous solid 
dispersions by confocal Raman microscopy. Eur. J. Pharm. Biopharm. 2016, 101:119-25, Copyright 
(2016), with permission from Elsevier. (45) 
 
 
In order to understand those differences in release behavior from two matrix systems, we applied 
CRM for non-invasive in situ investigation of the release and recrystallization processes directly in 
dissolution medium in static conditions. Due to swelling and gel formation during dissolution, the 
challenging task was to preserve the intactness of the diffusion barrier and follow the spatial 
distribution changes within the matrix. We applied virtual cross section imaging in x-z direction based 
on individual Raman spectra of tablet components. 
 
For each measurement, we initially focused on the tablet surface and let the laser penetrate into the 
sample down to the depth of around 20 μm. Tablets compressed from spray-dried Soluplus:aprepitant 
particles did not indicate any recrystallization or phase separation during dissolution testing (Fig. 6A). 
In contrast, the PVP:aprepitant matrix showed very fast phase separation (pure PVP depicted in light 
blue in Fig.6B) followed by drug recrystallization on the tablet surface (drug crystals depicted in pink 
in Fig.6B). 
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Figure 6. Raman imaging of compound distribution changes during dissolution. (A) Tablet 
(Soluplus:aprepitant) and (B) tablet (PVP:aprepitant). False colors depict the solid dispersion in dark 
blue, pure PVP in light blue, and pure drug crystals in pink, respectively. 
Reprinted from K. Puncochova, B. Vukosavljevic, J. Hanus, J. Beranek, M. Windbergs, F. Stepanek; 
Non-invasive insight into the release mechanisms of a poorly soluble drug from amorphous solid 
dispersions by confocal Raman microscopy. Eur. J. Pharm. Biopharm. 2016, 101:119-25, Copyright 
(2016), with permission from Elsevier. (45) 
 
 
The potential reason for the occurrence of this interesting phenomenon can be the difference in the 
chemical structures between two polymers. Soluplus® contains many hydrogen donors and acceptors 
responsible for interactions with the drug and solvent resulting in continuous release without any 
recrystallization of the poorly soluble API. PVP, on the contrary, has a hydrophilic character and 
exhibits fewer functional groups, thus leading to clear instabilities. 
 
This study elucidates that the combination of Soluplus® and PVP polymers in one matrix might 
improve slow drug release from the Soluplus® matrix, and at the same time inhibit precipitation of the 
API from the PVP matrix. Moreover, CRM represents an upcoming tool for non-invasive investigation 
of amorphous solid dispersions, as well as the influence of polymer properties on drug release kinetics 
from those drug delivery systems. 
 
Electrospun fiber mats as bio-inspired functional materials 
 
The rational development of bio-inspired functional materials is a very challenging task which 
involves examination of the complex interactions of human cells with material surfaces. In this study, 
we designed three different types of electrospun fiber mats with individual biomechanical 
characteristics and analyzed their component distribution and degradation kinetics using confocal 
Raman microscopy in order to finally correlate their physicochemical characteristics with their 
interactions with human cells. 
 
First, we electrospun one component fiber mats based on polycaprolactone (PCL), a FDA-approved, 
biocompatible polymer, which provided a mechanically stable and flexible fiber matrix. Further, in 
order to increase the wettability of the fiber surface and thus optimize cell attachment, we electrospun 
blend fibers based on PCL and gelatin (natural, water soluble polymer) mixture. As a third approach, 
we developed ‘‘hybrid’’ fibers by combining pure gelatin fibers with blend fibers (PCL/gelatin) into 
one scaffold (co-electrospinning) which intended to provide a dense fiber network for the initial cell 
attachment, but further upon slow degradation of gelatin, increasing porosity and more space for 
scaffold infiltration. 
 
As the spatial distribution of fiber compounds strongly affects the biomechanical properties of the 
material, we applied CRM to localize PCL and gelatin in blend fibers. Visualization of the electrospun 
fiber mats is, however, very challenging due to the three-dimensional orientation of the overall 
network and at the same time the very thin and delicate structure of the individual fibers. Based on z-
stack analysis, virtual slices of the fibers in different focal planes enabled spatially resolved and three-
dimensional visualization of the fiber composition. Interestingly, gelatin was mainly detected on the 
fiber surface, whereas the cores of the fibers consisted of PCL. These results were in good correlation 
with contact angle measurements which demonstrated a rather hydrophobic surface of PCL fibers, 
whereas blend and hybrid fibers, which contained water soluble gelatin, demonstrated improved 
hydrophilicity and excellent wettability. 
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Furthermore, we used SEM and CRM to examine the degradation kinetics of gelatin in “hybrid” fibers 
which compared to the other two fiber mats exhibited the best biomechanical properties. The 
degradation studies were performed in PBS buffer solution at 37 ºC during four months. Before 
degradation, two fiber types with different diameters were identified within the hybrid fiber mats using 
SEM. Nevertheless, chemically selective investigation using CRM was needed in order to differentiate 
between those fiber types. As shown in Fig. 7A, the thinner fibers were composed of gelatin (depicted 
in green) and the thicker ones of both PCL (depicted in red) and gelatin, representing blend fibers. 
During and after the degradation study, pure gelatin fibers were completely degraded, indicated by the 
absence of thin green fibers in the false color Raman image (Fig. 7B). At a higher magnification, the 
degradation of gelatin was also identified on the surface of the blend fibers. Before degradation, the 
fibers exhibited a smooth surface, mainly based on gelatin (Fig. 7C). After degradation, the dissolved 
gelatin leaves the small voids in the surface (Fig. 7D). 
 
 
 
Figure 7. Evaluation of degradation kinetics of gelatin from hybrid fiber mats using SEM and Raman 
analysis (PCL – red, gelatin – green); (A) before degradation; (B) after degradation; (C) before 
degradation at higher magnification exhibiting a smooth surface; (D) after degradation at higher 
magnification exhibiting a structured surface. 
Adapted from V. Planz, S. Seif, J.C. Atchison, B. Vukosavljevic, L. Sparenberg, E. Kroner, M. 
Windbergs; Three-dimensional hierarchical cultivation of human skin cells on bio-adaptive hybrid 
fibers. Integr. Biol. 2016, 8(7):775-84, Copyright (2016), with permission from the Royal Society of 
Chemistry. (143) 
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The degradation kinetics of the hybrid fiber mats matched the requirements for cell cultivation, by 
providing a dense gelatin-rich structure at the beginning, but subsequently high porosity of the fiber 
mat, leaving more space for cell infiltration and migration into the remaining part of the blend fibers. 
Here, CRM allowed for advanced visualization of bio-inspired functional materials, such as fiber mats, 
without any labeling. 
 
In summary, various solid drug delivery systems have successfully been visualized using confocal 
Raman microscopy in combination with optical profilometry, when necessary. Using different imaging 
approaches, it is possible to investigate component distribution as well as the underlying mass 
transport mechanisms of the drug from the matrix and to better understand the changes of the system 
upon contact with the dissolution medium. Overall, CRM enabled to fill the missing analytical gap 
between component distribution and in vitro dissolution testing, as well as the change of the 
dissolution rates from different dosage forms happening upon small differences in the formulation 
process or excipients. This corroborates that non-invasive Raman investigation represents a versatile 
technique for analytical characterization of carrier systems, thus supporting rational development of 
novel therapeutics and improved product safety. 
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3.2 Chemically Selective Investigation of the Non-Cellular Human Lung Barrier  
 
 
This chapter refers to the following publications: 
B. Vukosavljevic*, X. Murgia*, K. Schwarzkopf, U.F. Schaefer, C.M. Lehr, M. Windbergs; Tracing 
molecular and structural changes upon mucolysis with N-acetyl cysteine in human airway mucus. Int. 
J. Pharm. 2017, 533: 373–376. 
* These authors contributed equally to this work. 
 
B. Vukosavljevic, M. Hittinger, H. Hachmeister, C. Pilger, X. Murgia, M. Gepp, L. Gentile, H. 
Huwer, N. Schneider-Daum, T. Huser, C.M. Lehr, M. Windbergs; Vibrational spectroscopic imaging 
and live cell video microscopy for studying differentiation of primary human alveolar epithelial cells, 
submitted. 
 
 
The airway mucus of the conducting airways and the pulmonary surfactant secreted by alveolar 
epithelium represent a major non-cellular pulmonary barrier against external airborne threats. 
Therefore, insight into the biochemical mucus structure and surfactant secretion from alveolar 
epithelial cells upon their differentiation is of high interest for elucidating the course of lung diseases 
as well as for rational development of effective therapeutics for lung application.  
 
Applying confocal Raman microscopy (CRM) for biological investigation faces a challenge, as the 
Raman scattering of biological samples is inherently weak in comparison to chemical compounds. 
Nevertheless, the technique is sensitive enough to detect spectral differences for the differentiation of 
subcellular compartments. Here, very important prerequisite is the right substrate compatible with 
Raman imaging. In this context, we used calcium fluoride glass slides which are superior to standard 
plastic dishes, as their Raman bands do not interfere with signals originating from the sample and can 
easily be subtracted from the data set. 
 
In the presented studies, we applied CRM for label-free and chemically selective investigation of the 
human mucus microstructure and its changes upon chemical mucolysis, as well as for visualization of 
the gradual metamorphosis of alveolar type II (ATII) lung cells, in order to comprehensively 
investigate the non-cellular human lung barrier. Human airway mucus (144) and lung tissue samples 
(145) were collected from patients undergoing elective surgery, both after informed consent from all 
participants and/or their legal guardians and in compliance with a protocol approved by the Ethics 
Commission of the “Ärztkammer des Saarlandes” (file numbers 19/15 and 136/13). 
 
Human airway mucus 
 
As mucus lines the surface of the airways, its molecular and structural properties can affect 
pathophysiological processes as well as absorption of actives administered via the pulmonary route. 
Therefore, insight into the biomechanical mucus structure and better understanding of its composition 
and interactions is of major interest. In this study, the aim was to analyze structure and composition of 
the human airway mucus in its native state and after freeze drying using CRM as a label-free 
technique. 
 
Airway mucus is a complex hydrogel mainly consisting of water (95% w/w) with incorporated 
glycoproteins (mucins, 2-5% w/w), non-mucin proteins, lipids, salts, DNA, enzymes, cellular debris, 
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and pulmonary surfactant. Systematic analysis in its native state is very challenging, as it requires 
conserving the hydration state of the hydrogel to avoid collapsing of the gel mesh. In this context, 
CRM is an upcoming tool as it enables chemically selective investigation without sample 
manipulation (e.g. staining, fixation), which are usual requirements for well-established techniques.  
 
Upon investigation of different human airway mucus samples, we successfully differentiated 
individual signal contributions of pulmonary surfactant (depicted in pink, consisting of phospholipids 
associated with surfactant proteins) and mucus matrix (depicted in green, consisting of glycoproteins 
and lipids) and resolved their spatial distribution, as shown in representative false color Raman image 
in Fig. 8. The surfactant spectrum was very distinctive and comparable to dipalmitoyl 
phosphatidylcholine (DPPC, Figure 8A), which is a major constituent of the pulmonary surfactant 
(146). The most important spectral assignments of DPPC (reference spectrum presented in Fig. 8A) 
and surfactant-like spectra were: choline head group at 717 cm-1, three distinct peaks at 1066 cm-1, 
1102 cm-1 and 1128 cm-1 representing the carbon backbone vibrations, and aliphatic ester at 1740 cm-1. 
 
 
 
Figure 8. Analysis of the native human airway mucus: (A) Single Raman spectra assigned to the 
mucus matrix, to pulmonary surfactant and to dipalmitoyl phosphatidylcholine (DPPC) as a reference, 
respectively; (B) False color Raman image representing the spatial distribution of the pulmonary 
surfactant in the mucus matrix (xy-scan). False colors depict the mucus matrix in green, and the 
pulmonary surfactant in pink, respectively. 
Reprinted from B. Vukosavljevic, X. Murgia, K. Schwarzkopf, U.F. Schaefer, C.M. Lehr, M. 
Windbergs; Tracing molecular and structural changes upon mucolysis with N-acetyl cysteine in 
human airway mucus. Int. J. Pharm. 2017, 533: 373–376, Copyright (2017), with permission from 
Elsevier. (147) 
 
 
As Raman imaging of the spatially resolved compound distribution within the mucus mesh was 
exacerbated by the samples` gel-like structure and the high water content, in the next step we 
investigated freeze-dried mucus samples using SEM and CRM. SEM revealed the typical mesh-like 
structure with a highly heterogeneous pore size, ranging from pores in the nanoscale up to pores in the 
range of 1-10 µm (Fig. 9A).  
 
Furthermore, we applied Raman imaging for chemically selective and label-free visualization. Two 
Raman spectra, one consisting of all prominent glycoprotein and lipid related peaks, representing the 
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mucus matrix, and the other one consisting of peaks corresponding to disulfide bonds (-S-S-) at 492 
cm-1 and the surfactant related choline head group (-N+) at 717 cm-1 were successfully identified (Fig. 
9B). After conversion of the Raman spectra into false-color images, areas in which mucins interact by 
disulfide binding could be visualized (Fig. 9C). These areas, depicted in blue, were located in the 
edges of thin mucin fibers, thus most likely stabilizing the fragile macrostructure of human airway 
mucus. 
 
 
 
Figure 9. Analysis of the freeze-dried mucus: (A) SEM image; (B) two individual single Raman 
spectra corresponding to the mucus matrix (red) and cysteine-rich domains (blue) with the spectral 
region of interest highlighted; (C) false color Raman image (same color coding like in 3B). 
Reprinted from B. Vukosavljevic, X. Murgia, K. Schwarzkopf, U.F. Schaefer, C.M. Lehr, M. 
Windbergs; Tracing molecular and structural changes upon mucolysis with N-acetyl cysteine in 
human airway mucus. Int. J. Pharm. 2017, 533: 373–376, Copyright (2017), with permission from 
Elsevier. (147) 
 
 
Moreover, in order to investigate potential changes in the mucus microstructure upon mucolytic 
treatment, we incubated the human airway mucus with N-acetylcysteine (NAC, 10% w/w), as an 
established therapeutic mucolytic agent. Here, SEM images of NAC-treated samples showed a 
partially collapsed mesh structure contrasting the structure of non-treated mucus. Additionally, Raman 
spectra of freeze dried mucus samples after mucolysis revealed the presence of free thiol (-SH) groups 
at 2560-2590 cm-1, thus proving the reduction of the disulfide bonds within the mucus matrix upon 
mucolytic treatment. 
 
Our approach for label-free investigation of human airway mucus provides new insights into its 
microstructure and brings Raman microscopy in focus as an upcoming tool for elucidation of the 
interaction mechanisms between the mucus and airborne threats. 
 
Differentiation of primary human alveolar epithelial cells 
 
In order to thoroughly investigate alveolar surfactant production and secretion, we further studied 
differentiation of primary human alveolar epithelial cells. The alveolar epithelium in the peripheral 
lung is mainly composed of barrier forming alveolar type I (ATI) and surfactant producing alveolar 
type II (ATII) cells. As ATII cells act as progenitors for the ATI phenotype, upon differentiation, they 
extracellularly secret alveolar surfactant and significantly grow and flatten in order to form the air-
blood barrier. Here, we applied a combination of confocal fluorescence microscopy and spontaneous 
Raman as well as coherent anti-Stokes Raman scattering (CARS) microscopy to study the 
differentiation of human ATII cells. 
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We isolated primary human alveolar epithelial cells from lung tissue of patients undergoing lung 
resection and cultivated them for seven days (145). In order to visualize surfactant rich vesicular 
structures, which are typically considered as an indicator for ATII cells, and their gradual 
disappearance over time during cell differentiation, in the first step we used laurdan as a reference 
fluorescence marker for our study. Laurdan detects time and temperature dependent changes in 
membrane phase properties and allowed for visualization of individual lipid vesicles. 
 
In the next step, we applied label-free Raman microscopy techniques to investigate the cell 
differentiation process based on the spectral information comprising content, distribution, and 
concentration of cellular biopolymers (such as DNA, RNA, proteins, lipids, and carbohydrates) on the 
molecular level. After spectral assignment of the Raman peak patterns, we were able to distinguish the 
signal contributions of nucleus, cytoplasm, membrane, and lipid vesicles (phospholipid vibrations) 
characteristic of the ATII phenotype (Fig. 10A). The Raman spectrum of lipid vesicles (depicted in 
pink) was very distinctive, with major contributions by spectral patterns of dipalmitoyl 
phosphatidylcholine (DPPC), a major constituent of the pulmonary surfactant. Upon differentiation, 
these vesicles fuse with the cell membrane and secrete the alveolar surfactant into the extracellular 
environment. ATI-like cells, however, yielded spectra with significantly less lipid content and absence 
of vesicular structures (Fig.10B). 
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Figure 10. Differentiation of alveolar epithelial cells in primary culture visualized by confocal Raman 
microscopy. A. Raman spectra (full, raw spectra and normalized fingerprint region) of different 
cellular compartments: lipid vesicles (pink), nucleus (blue), cytoplasm (black), cellular membrane 
(green), and cytochrome c (yellow), respectively; B. Representative Raman images for days 1-7 (d1-
d7), respectively. The red line at d2 depicts the focal plane of the X-Z cross section presented next to 
the X-Y scan (scale bars 10 µm). 
B. Vukosavljevic, M. Hittinger, H. Hachmeister, C. Pilger, X. Murgia, M. Gepp, L. Gentile, H. 
Huwer, N. Schneider-Daum, T. Huser, C.M. Lehr, M. Windbergs; Vibrational spectroscopic imaging 
and live cell video microscopy for studying differentiation of primary human alveolar epithelial cells, 
submitted. 
 
 
Upon differentiation, alveolar epithelial cells dramatically grow and flatten, making their visualization 
with CRM very challenging. Therefore, we additionally applied CARS microcopy which allowed for a 
3D visualization of alveolar surfactant rich vesicles within ATII cells and their secretion. Finally, as an 
additional investigational approach, we applied hyperspectral (HS) CARS imaging. After scanning the 
samples in the spectral range from 2700 to 3050 cm-1, we were able to spectrally differentiate lipid rich 
vesicles (2845 cm-1) from cellular proteins (2930 cm-1) according to their vibrational signature, and 
thus to further corroborate the confocal Raman microscopy experiments (Fig. 11). 
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Figure 11. Hyperspectral (HS) CARS overlay images of ATII cells at day 1, 2 and 3. Three individual 
channels representing the lipid rich environment depicted in pink; nuclei depicted in blue; background 
depicted in grey, respectively (scale bars 1 µm). 
B. Vukosavljevic, M. Hittinger, H. Hachmeister, C. Pilger, X. Murgia, M. Gepp, L. Gentile, H. 
Huwer, N. Schneider-Daum, T. Huser, C.M. Lehr, M. Windbergs; Vibrational spectroscopic imaging 
and live cell video microscopy for studying differentiation of primary human alveolar epithelial cells, 
submitted. 
 
 
In this section, it is shown that confocal Raman microscopy is well suited for the analysis of complex 
human samples, primary lung cells as well as the airway mucus. As a complementary method for 
cellular investigations coherent anti-Stokes Raman scattering (CARS) microscopy contributed to a 
better understanding of complex biochemical changes happening upon cellular differentiation. These 
results do not only enrich the knowledge about the mucus microstructure and human alveolar 
epithelial cells differentiation, but also, pave the path to further label-free pulmonary surfactant corona 
investigation and rational development of future lung therapeutics. 
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3.3 Non-Invasive In Vitro Uptake Visualization of Squalenoylated Nanoparticles into Breast 
Cancer Cells with Different LDLR Expression 
 
 
This chapter refers to the following publications: 
Buchy, B. Vukosavljevic, M. Windbergs, D. Sobot, C. Dejean, S. Mura, P. Couvreur, D. Desmaele; 
Synthesis of a deuterated probe for the confocal Raman microscopy imaging of squalenoyl 
nanomedicines. Beilstein J. Org. Chem. 2016, 12:1127-1135. 
 
D. Sobot, S. Mura, M. Rouquette, B. Vukosavljevic, F. Cayre, E. Buchy, G. Pieters, M. Windbergs, D. 
Desmaele, P. Couvreur; Circulating lipoprotein: a Trojan horse guiding squalenoylated drugs to LDL-
accumulating cancer cells. Mol. Ther. 2017; 25(7):1596-1605. 
 
 
In the last few decades, nanomedicines were widely investigated as an approach for treatment of 
severe diseases such as cancer, intracellular infections, neurodegenerative diseases, etc. Nanocarrier 
systems designed for these purposes often exhibited a significant improvement in pharmacokinetics, 
biodistribution, stability, specificity, therapeutic efficacy and toxicity compared to the free active 
compounds, thus increasing potential for prudent application of those systems. Due to an emerging 
understanding of the complex comorbidities as well as of potential toxicological effects of 
nanotherapeutics on the subcellular level, their interaction and potential uptake into cells represent one 
of the first steps to study their fate in the human body. In this context, there is a strong need for 
advanced analytical methods for investigation of pure nanomaterials, cells and their interactions. 
 
Hence, confocal Raman microscopy (CRM) represents an upcoming analytical tool. As described in 
the previous chapter, this method does not only allow for spectral differentiation of subcellular 
compartments, but also for intracellular visualization of nanocarrier systems. However, for the 
simultaneous detection and visualization of both, cellular compartments and the drug/carrier system, 
significant spectral contrast is usually an obstacle. This is especially the case when dealing with low 
drug concentrations or biological structures such as peptide drugs or nucleoside analogues. 
 
This chapter refers to the application of CRM for studying bioinspired nanocarriers, the obstacles 
occurring upon simultaneous detection of those systems and biological material, as well as the 
potential solution to overcome insignificant spectral contrast. We investigated the cellular uptake and 
intracellular localization of squalenoylated nanoparticles, as bioinspired nanocarrier systems. The 
chemical conjugation of the anticancer drug gemcitabine (Gem) to squalene (SQ) - a natural and 
biocompatible triterpene, led to the formation of the prodrug (GemSQ) which spontaneously self-
assembles in water, forming nanoparticles (GemSQ NPs) (148). Recently, it has been revealed that 
GemSQ NPs interact with lipoproteins (especially low density lipoproteins-LDL) in the blood, thus 
allowing for indirect cancer cell targeting, due to their high lipoprotein receptors expression (149). In 
order to prove this on the subcellular level, we used CRM for label-free analysis of GemSQ NPs, their 
internalization and interaction with MDA-MB-231 and MCF-7, two breast cancer cell lines with 
different LDL receptors expression levels. 
 
First attempts to detect and locate lipid based GemSQ NPs within the cell were unsuccessful because 
each cellular compartment (i.e. nucleus, cytoplasm, and intracellular lipid droplets) contained certain 
lipids which contributed to the overall Raman spectrum of the cell. In this particular case, Raman 
detection of the GemSQ NPs was not possible due to intracellular lipid droplets which are omnipresent 
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in highly metabolically active cancer cells. For circumventing this problem, we repeated the same 
experiments using deuterized NPs (GemSQ-d6), an approach applied for increasing the Raman 
sensitivity of the molecules of interest (8). 
 
Inclusion of specific functional groups such as alkyne, or compound deuterization gained attention as 
potential markers to increase the Raman scattering activity and specifity as they display Raman peaks 
in the silent region (1800-2800 cm−1), a part of the spectrum where natural molecular vibrations of 
cells rarely occur, and thus not perturbe with the analysis of live cells (4-7). 
 
The synthesis of deuterated squalenic acid was achieved from natural squalene through the Shapiro 
reaction (150) (0.6% yield). The synthesized deuterated squalenic acid was further coupled to 
gemcitabine to provide the deuterated analogue of squalenoyl gemcitabine (GemSQ-d6). The GemSQ 
and GemSQ-d6 NPs suspensions were prepared in a single step by nanoprecipitation of an ethanolic 
solution in milli-Q water (148). After spontaneous formation of the NPs, the organic solvent was 
evaporated under vacuum (Fig. 12A). The individual Raman spectra of the raw substances as well as 
of the particles were recorded (Fig. 12B). As depicted in Fig. 12C and Fig. 12D, the Raman spectra of 
the deuterated and non-deuterated compounds revealed no differences in their scattering patterns 
except from the unique spectral bands of the deuterium isotope generated in the silent spectral region 
(around 2200 cm-1). In addition, both analogues showed the same self-assembling properties (120).  
 
 
Figure 12. (A) Sketch depicting the procedure of preparing the NPs; (B) Single Raman spectra of 
GemSQ-d6 NPs, GemSQ NPs, gemcitabine and squalenic acid, respectively; (C) Single Raman 
spectra of deuterated GemSQ-d6 NPs (red) and GemSQ NPs (black); (D) Close-up showing the 
difference between deuterated and non-deuterated compounds. 
Reprinted from E. Buchy, B. Vukosavljevic, M. Windbergs, D. Sobot, C. Dejean, S. Mura, P. 
Couvreur, D. Desmaele; Synthesis of a deuterated probe for the confocal Raman microscopy imaging 
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of squalenoyl nanomedicines. Beilstein J. Org. Chem. 2016, 12:1127-1135, Copyright (2016), with 
permission of the Beilstein Journal of Organic Chemistry (open access). (150) 
 
 
In the next step, we aimed for label-free visualization of cancer cells and their interaction with 
deuterated nanoparticles. Control experiments (cell imaging prior to NP incubation) revealed that 
MDA-MB-231 cells were much more abundant in intracellular lipid droplets (depicted in cyan blue) 
than MCF-7 cells, thus indicating a difference in the lipid metabolism between the two cell lines (Fig. 
13A and 13B). Furthermore, the use of GemSQ-d6 NPs allowed for their detection and visualization 
even in the lipid-rich intracellular environment, based on the unique spectral bands of the deuterium 
isotope. After 2 hours incubation with GemSQ-d6 NPs, a significant intracellular accumulation was 
observed in MDA-MB-231 cells (Fig. 13C), whereas no NPs were detected in MCF-7 cells under the 
same conditions (Fig. 13D), most likely due to their lower LDLR expression. 
 
 
 
Figure 13. Confocal Raman images of MDA-MB-231 and MCF-7 breast cancer cell lines showing a 
comparison of 2H-SQGem NPs uptake: (A, B) Representative images of non-treated MDA-MB-231 
(A) and MCF-7 (B) cells (control). (C and D) MDA-MB-231 (C) and MCF-7 (D) cells incubated with 
NPs (77 mM) for 2 hours at 37°C. False-color Raman images were generated based on different 
scattering patterns of different cellular compartments. False colors visualize nucleus in dark blue, 
cytoplasm in white, lipid vesicles in cyan, and 2H-SQGem in pink. Scale bars, 10 µm. 
Reprinted from D. Sobot, S. Mura, M. Rouquette, B. Vukosavljevic, F. Cayre, E. Buchy, G. Pieters, 
M. Windbergs, D. Desmaele, P. Couvreur; Circulating lipoprotein: a Trojan horse guiding 
squalenoylated drugs to LDL-accumulating cancer cells. Mol. Ther. 2017; 25(7):1596-1605, 
Copyright (2017) American Society of Gene & Cell Therapy (ASGCT), with permission from 
ASGCT. (120) 
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Altogether, this chapter describes the in vitro uptake of bioinspired squalenoylated nanoparticles into 
two breast cancer cell lines with different LDL receptors expression levels. In order to detect and 
visualize the lipid-based nanocarrier systems within the lipid-rich intracellular environment, we 
applied compound deuterization, to detect the lipid-based carrier within the endogeneous cellular 
lipids Different particle uptake in two cell lines confirmed the assumption of the LDLR mediated 
cellular uptake and paved the way for label-free intracellular trafficking of bioinspired advanced 
therapeutics for selective drug delivery by confocal Raman microscopy. 
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4  Conclusions and Outlook 
 
This thesis describes the successful application of confocal Raman microscopy (CRM) for label-free 
and chemically selective characterization and advanced visualization of a large variety of 
pharmaceutical samples ranging from solid dosage forms, primary cells and their differentiation, up to 
the cellular interactions with deuterated nanocarrier systems. 
 
The first chapter describes Raman microscopy as a valuable tool for chemical imaging of different 
classic solid dosage forms, i.e. tablets and pellets, but also electrospun fiber mats as bioinspired 
functional materials, for investigating the effect of release and degradation on final properties of drug 
delivery systems. Chemical imaging of component distribution within a pellet, for example, was 
necessary to understand the drug release mechanism from a coated drug delivery system without any 
labeling, and to correlate it to drug release profiles in two different media. In the case of in situ drug 
release investigation from the tablet based on amorphous solid dispersions, CRM allowed for the 
elucidation of the influence of the polymer properties on the drug form and dissolution mechanisms. 
Overall, based on Raman analysis, we investigated not only component distribution, but also the 
underlying mass transport mechanisms upon contact with the dissolution or degradation medium and 
correlated the dissolution profiles with excipients properties and fabrication processes. 
 
The subsequent chapter introduced CRM for studying the non-cellular pulmonary barrier represented 
by the human airway mucus in the peripheral lung and alveolar surfactant secreted by the primary 
human alveolar epithelium. In the first study, we were successfully able to chemically resolve the 
pulmonary surfactant from the human mucus matrix and show its spatial distribution. In addition, we 
visualized cysteine-rich domains (-S-S-) within the mucus mesh prior to mucolysis and the reduction 
of disulfide bonds after incubation with a thiol-based mucolytic agent, N-acetyl cysteine. In the next 
study, we used the knowledge about the prominent spectral pattern of alveolar surfactant for 
identification and gradual metamorphosis of primary human alveolar epithelial cells by applying 
spontaneous Raman and coherent anti-Stokes Raman scattering (CARS) microscopy. Here, gradual 
morphological and molecular changes during differentiation of alveolar type II (ATII) towards ATI-
like cells were correlated to chemically selective Raman spectra. The ATII phenotype was identified 
based on strong and localized phospholipid vibrations (specifically phosphatidyl choline); however, 
the ATI-like phenotype yielded spectra with significantly less lipid content and absence of vesicular 
structures. As the intracellular lipid vesicles generate a strong CARS signal, we applied CARS 
microscopy for complementary 3D visualization of alveolar surfactant rich vesicles within ATII cells 
and their secretion upon cell differentiation. Finally, hyperspectral CARS imaging enabled the 
distinction between cellular proteins and lipids according to their vibrational signatures. Despite the 
low scattering intensities of the cells, especially flattened ATI-like cells, label-free analysis was 
pursued effectively without sacrificing chemical selective detection as comparative fluorescence 
microscopy studies proved. 
 
In the final chapter, we describe the in vitro uptake of squalenoylated nanoparticles into two breast 
cancer cell lines with different LDL receptors expression. Firstly, in order to visualize the lipid-based 
nanocarrier systems inside of the lipid-rich intracellular environment, we applied deuterization as an 
approach for increasing the Raman sensitivity of the molecule of interest. Further, the contribution of 
the LDLR in the cellular uptake of SQGem nanoparticles was investigated on MDA-MB-231 and 
MCF-7 breast cancer cells, displaying respectively high and low levels of LDLR expression. The use 
of nanoparticles resulting from the self-assembly of a deuterated SQGem bioconjugates enabled 
differentiation of the endogenously similar Raman spectra of SQ-based nanoparticles and intracellular 
lipid droplets due to the unique spectral bands of the deuterium isotope generated in the so called 
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“silent region” (around 2200 cm-1) in which no significant spectral contributions of other 
biomacromolecules are observed. After 2h incubation with 2H-SQGem NPs, a significant intracellular 
accumulation was observed in MDA-MB-231 cells, whereas no NPs were detected in MCF-7 cells 
under the same conditions. However, after longer incubation times (72 h), both cell lines exhibited a 
significant uptake of 2H-SQGem NPs, thus confirming the theory of the LDLR mediated uptake. 
 
Although versatile and very promising, confocal Raman microscopy is a challenging analytical tool 
which requires a complex study design, data post-processing and thorough interpretation. In addition 
to significant contribution to the formulation design and production of advanced drug delivery 
systems, the method looks very promising for label-free intracellular trafficking of advanced 
therapeutics for selective drug delivery.For these purposes, sophisticated multivariate data methods 
used for spectral post-processing are continuously explored in the field as they enable clarification of 
delicate spectral changes, especially in a biological system. Moreover, the long acquisition times 
required for analyzing biological samples due to their low Raman scattering intensity was overcome 
by applying a non-linear coherent Raman technique. 
 
Altogether, chemical imaging undoubtedly provided important analytical results and enabled a 
comprehensive investigation of drug delivery systems, complex biological samples, as well the 
interaction of cells and bioinspired nanocarriers. CRM is successfully proven as a tool for elucidation 
of complex drug release mechanisms, investigation of the non-cellular lung barrier, as well as for 
visualization of the particle uptake. As shown in this thesis, confocal Raman microscopy is well-suited 
for profound analysis of pharmaceutical samples and can support more rational development of novel 
therapeutics and improved product safety. The application of this versatile method is expected to grow 
further in the future.  
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5  Original Publications 
 
5.1  Novel Insights into Controlled Drug Release from Coated Pellets by Confocal Raman 
Microscopy 
 
 
 
 
Novel insights into controlled drug release from coated pellets by confocal Raman microscopy 
 
B. Vukosavljevic, L. De Kinder, J. Siepmann, S. Muschert, M. Windbergs 
J. Raman Spectrosc. 2016, 47:757-762. 
 
 
 
 
 
 
 
Reprinted from Journal of Raman Spectroscopy, Novel insights into controlled drug release from 
coated pellets by confocal Raman microscopy, 47, B. Vukosavljevic, L. De Kinder, J. Siepmann, S. 
Muschert, M. Windbergs, 757-762, Copyright (2016) John Wiley & Sons, Ltd., published in Wiley 
Online Library, with permission from John Wiley & Sons, Ltd. 
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5.2 Non-Invasive Insight into the Release Mechanisms of a Poorly Soluble Drug from 
Amorphous Solid Dispersions by Confocal Raman Microscopy 
 
 
 
 
Non-invasive insight into the release mechanisms of a poorly soluble drug from amorphous solid 
dispersions by confocal Raman microscopy 
 
K. Puncochova*, B. Vukosavljevic*, J. Hanus, J. Beranek, M. Windbergs, F. Stepanek  
Eur. J. Pharm. Biopharm. 2016, 101:119-25. 
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Reprinted from European Journal of Pharmaceutics and Biopharmaceutics, Non-invasive insight into 
the release mechanisms of a poorly soluble drug from amorphous solid dispersions by confocal Raman 
microscopy, 101, K. Puncochova*, B. Vukosavljevic*, J. Hanus, J. Beranek, M. Windbergs, F. 
Stepanek, 119-125, Copyright (2016) Elsevier B.V., published by Elsevier Inc., with permission from 
Elsevier. 
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5.3 Three-Dimensional Hierarchical Cultivation of Human Skin Cells on Bio-Adaptive 
Hybrid Fibers 
 
 
 
 
Three-dimensional hierarchical cultivation of human skin cells on bio-adaptive hybrid fibers 
 
V. Planz, S. Seif, J.C. Atchison, B. Vukosavljevic, L. Sparenberg, E. Kroner, M. Windbergs  
Integr. Biol. 2016, 8(7):775-84. 
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5.4 Tracing Molecular and Structural Changes upon Mucolysis with N-Acetyl Cysteine in 
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